Zydus Lifesciences Limited Press Release Aug 01 2026
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectable facility, which has been classified with Voluntary Action Indicated status. The inspection took place at the Zydus Biotech Park in Ahmedabad and was conducted in early May. This announcement serves as a disclosure in accordance with regulatory requirements for listed companies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Jul 23 2026
- Zydus Lifesciences Limited Press Release Jul 03 2026
- Press Release May 28 2026
- Zydus Cancer Hospital, Ahmedabad marks 200+ Stereotactic Radiotherapy (SRT)/SRS for Brain Tumours
- Press Release May 19 2026
Later from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Aug 04 2026
- Zydus Lifesciences Limited Press Release Aug 11 2026
- Zydus Hospitals Sets New Benchmarks in High-Risk Pregnancy and Complex Gynaecological Care
- Zydus Lifesciences Limited Press Release Aug 21 2026
- Zydus Lifesciences Limited Press Release Aug 31 2026
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences